TECHWIRE 30
(CIX: WRAL30)  1,165.32  down arrow-1.62  (-0.14 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: Apple)  123.25  down arrow-0.99  (-0.8 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: QUINTILES)  67.26  up arrow+0.97  (1.46 %)  Updated: 06:40 PM EDT, Mar 27 2015
(OP: BASF SE)  100.62  up arrow+0.99  (1 %)  Updated: 05:20 PM EDT, Mar 27 2015
(NQ: BioCryst)  8.30  up arrow+0.19  (2.34 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: BioDelivery)  13.89  up arrow+0.14  (1.02 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: CEMP)  32.00  up arrow+1.01  (3.26 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: Cisco Systems)  27.13  up arrow+0.04  (0.15 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: Cree)  35.03  up arrow+0.02  (0.06 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: DARA)  0.79  down arrow-0.01  (-1.1 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: EMC CORPORATION)  25.17  down arrow-0.64  (-2.48 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NQ: Extreme Networks)  3.08  down arrow-0.02  (-0.65 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: FB)  83.30  up arrow+0.29  (0.35 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: GLAXOSMITHKLINE)  47.02  up arrow+0.36  (0.77 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NQ: GOOG)  548.34  down arrow-6.83  (-1.23 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: IBM)  160.40  down arrow-0.19  (-0.12 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NY: LH)  127.15  up arrow+1.35  (1.07 %)  Updated: 06:40 PM EDT, Mar 27 2015
(OP: Lenovo Group)  28.57  down arrow-0.51  (-1.75 %)  Updated: 05:20 PM EDT, Mar 27 2015
(NY: MRK)  57.75  up arrow+0.15  (0.26 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NQ: Microsoft Corp)  40.97  down arrow-0.24  (-0.58 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: NTAP)  35.10  down arrow-0.45  (-1.27 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: NOVARTIS AG)  100.40  up arrow+0.84  (0.84 %)  Updated: 06:40 PM EDT, Mar 27 2015
(OP: Novozymes A/S)  45.95  down arrow-0.17  (-0.36 %)  Updated: 05:20 PM EDT, Mar 27 2015
(NY: PFIZER)  34.53  up arrow+0.37  (1.08 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NQ: Pozen)  7.68  up arrow+0.07  (0.92 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NY: RED HAT)  76.52  up arrow+1.16  (1.54 %)  Updated: 06:40 PM EDT, Mar 27 2015
(NQ: BBRY)  9.46  up arrow+0.16  (1.72 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: Salix)  172.60  down arrow-0.03  (-0.02 %)  Updated: 08:10 PM EDT, Mar 27 2015
(NQ: SQI)  17.12  up arrow+0.09  (0.53 %)  Updated: 08:10 PM EDT, Mar 27 2015

Posts tagged “Biotech & Life Science”

Updated 6:16 a.m. Friday

CoLucid Pharma leaves RTP; Cree LEDs for rural areas; new Samsung, HTC phones; 'Voice'-like app; PayPal's fine

Bulldog In today's Bulldog wrapup of technology and life science news: CoLucid Pharmaceuticals leaves the Triangle; Cree targets rural areas with new LEDs; new Samsung and HTC phones coming April 10; a new "American Idol"- or "Voice"-like app launches; and PayPal pays $7.7 fine.

Updated 10:39 a.m. Wednesday

Google Fiber expands; Jim Goodnight's venture play; non-GMO food label; new Instagram app; GSK's next HQ in Asia

Bulldog Bulletin In today's Bulldog wrapup of technology and life science news: Google Fiber is expanding; Jim Goodnight's new venture play is biotech; a proposed label for non-GMO foods; Instagram has a new app; and GSK is building a new Asian headquarters.

10:24 a.m. Wednesday

Life beyond GSK: The entrepreneurial career options

Biotech   At an event put on by the North Carolina Biotechnology Center and supported by GlaxoSmithKline, more than 300 people who are losing their jobs at GSK through layoffs gathered to hear about possible options for future employment. "There is life beyond GSK," former GlaxoWellcome CEO Robert Ingram tells the crowd.

Updated 6:07 a.m. Wednesday

Premium Lock RTP-based T3D Therapeutics lands $1.8M grant for Alzheimer's

In the latest news of progress on the Alzheimer's front, RTP-based T3D Therapeutics on Tuesday disclosed that it had received a $1.8 million grant from the National Institutes of Health for its development of a potential Alzheimer's treatment.

Updated 12:22 p.m. Monday

Cisco phone hack vulnerability; Google Glass not dead; gluten-free wheat; Square's biz fee; Ikea stops online mag in Russia

Bulldog In today's Bulldog wrapup of tech and biotech news: Cisco warns about a vulnerability in its Internet phones; Google's Eric Schmidt backs Glass; researchers to seek gluten-free wheat; Square's "Cash" app for businesses; and Ikea drops its online magazine in Russia over gay law concerns.

8:44 a.m. Monday

Biogen drops Idec from name, says change reflects drug firm's focus

Biogen is going back to its roots, changing the company's name after being known as Biogen Idec since 2003. The change reflects the focus of the company now vs. when it merged with Idec in 2003.

New sign at Biogen's RTP campus New sign at Biogen's RTP campus

6:09 a.m. Monday

WTW in review: Last week's headline news (Part 1)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week. We published so many stories last week, we had to post this in two parts.

6:01 a.m. Monday

WTW in review: Last week's headline news (Part 2)

Week in review Here's a look back at technology, life science and other related news as reported in WRAL TechWire last week. We published so many stories last week, we had to post this in two parts.

5:58 a.m. Monday

Making news? Have an opinion? Share it with WRAL TechWire

Contribute to WRALTechWire WRALTechWire is continuously expanding its content lineup, and we want you to participate. We are looking for news and analysis about all things tech and life science from people who know their business.

March 20

Despite Bill Gates' warning, will world prepare for the next Ebola?

Bill Gates The Bill & Melinda Gates Foundation took a major role in trying to find a vaccine to treat Ebola, even providing funding to Durham-based Chimerix. Now, Bill Gates is warning that the world must prepare for future epidemics. If we are smart, we will listen and learn from what's happened from an outbreak that has killed some 10,000 people.

March 20

FDA approves genetically engineered potatoes, apples as safe

FDA Potatoes and Apples ​Potatoes that won't bruise and apples that won't brown are a step closer to grocery store aisles. The Food and Drug Administration on Friday approved the genetically engineered foods, saying they are "as safe and nutritious as their conventional counterparts."

Updated March 20

Biogen reports possible breakthrough in search for Alzheimer's drug

Brain power  Biogen Idec reports that a possible treatment for Alzheimer's under development by the company for the "first time" demonstrates the capability of reducing disease-related plaque in the brain and in slowing mental impairment in patients.

March 20

AT&T's $40M error; GSK job cuts; Amazon 1-hour delivery; Salix $78M parachutes; GSK inhaler; China freedom group attacked

Bulldog In today's Bulldog wrapup of technology and life science news: AT&T takes a $40M hit in a lawsuit; GSK is cutting 150 jobs in Pa.; Amazon expands 1-hour delivery service; Salix handing out $78M in golden parachutes; GSK wins OK for inhaler; and a China web freedom group is under attack.

March 19

Premium Lock GSK exec: 'Social responsibility' led to Ebola project

Ebola A senior executive at troubled drug giant GlaxoSmithKline says "social responsibility" is a major reason for its attempts to develop a vaccine to treat Ebola. Resources were diverted from other projects to support the Ebola fight, he says.

March 19

Premium Lock Fresh from $20M round, Durham startup Scioderm launches Phase 3 trial of treatment for 'butterfly children'

Durham-based Scioderm is launching today a Phase 3 clinical trial of a drug it hopes will be the first treatment for EB, "the worst disease you've never heard of." The rare skin disorder is also known for creating "butterfly children" who are adorned with bandages in an attempt to fight the disease.

March 19

UNC-TV to air report touting NC Arboretum as a jobs engine

Most people who visit the North Carolina Arboretum in Asheville enjoy it as a vacation stop at a "plant zoo" where the beauty and variety of the state's mountain vegetation can be enjoyed in a magnificent Appalachian setting. But the Arboretum is also an increasingly important scientific and economic resource for North Carolina.

Bent Creek Institute Bent Creek Institute

March 18

GSK invests $25M in global Alzheimer's venture fund

Brain power  GlaxoSmithKline, Biogen, other major drugmakers, the British government and a top Alzheimer's research charity are pooling more than $100 million to create a global fund to accelerate efforts to find a treatment or even a cure for the mind-robbing disease within a decade.

March 17

Southeast consortium building livestock feed grain system

Livestock producers in North Carolina and other mid-Atlantic states are sharing some high-tech tools to fix a big, expensive food disparity. A collaborative venture is challenging academic research and industry experts in North and South Carolina, Virginia and Maryland to put their heads together and find ways to produce at least 50 percent more animal feed grain from crops especially well-suited to conditions in the mid-Atlantic region.

New feed for livestock? New feed for livestock?

Updated March 17

Blackberry-IBM-Samsung secure tablet; Cablevision-HBO Now; GSK Ebola update; Facebook's buy; Lyft lawsuit

Bulldog In today's wrapup of technology and life science news: BlackBerry joins with IBM and Samsung to develop a secure tablet; GSK's Ebola vaccine advances; Cablevision hooks up with HBO Now; Facebook's latest buy; and did Lyft cheat drivers?

March 16

Valeant ups bid for Salix Pharmaceuticals to $11.1B

Salix        The price for Raleigh-based Salix Pharmaceuticals keeps going up. On Monday, Valeant upped its offer to Salix after Endo Pharmaceutical entered the bidding last week.

Techwire Inside Partners
The Skinny: A Blog by Rick Smith